Genomic testing in biliary tract cancers

Intraoperative Radiotherapy

Cancer survivors' stories: An African perspective

ERMES study suggests a strategy of de-escalation with only cetuximab in first line therapy for RAS and BRAF wild type mCRC

ESMO 2022: Highlights, commentary and analysis

Fruquintinib provides improvement in overall survival for refractory mCRC

Cabozantinib in combination w/ nivolumab and ipilimumab of IMDC intermediate or poor risk significantly improved PFS vs PBO

A new era of early cancer detection with blood test may change cancer screening paradigms

New era of early cancer detection blood tests on the horizon

Hyperthermic intraperitoneal chemo for locally advanced colon cancer

Prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19

New data presented at ESMO for multi-cancer early detection